Gene therapy for inherited retinal degeneration.
作者信息
Ali R R, Reichel M B, Hunt D M, Bhattacharya S S
机构信息
Department of Molecular Genetics, Institute of Ophthalmology, UCL, London.
出版信息
Br J Ophthalmol. 1997 Sep;81(9):795-801. doi: 10.1136/bjo.81.9.795.
Abstract
摘要
相似文献
1
Gene therapy for inherited retinal degeneration.
Br J Ophthalmol. 1997 Sep;81(9):795-801. doi: 10.1136/bjo.81.9.795.
2
Gene Therapy for Retinal Degeneration.
Cell. 2018 Mar 22;173(1):5. doi: 10.1016/j.cell.2018.03.021.
3
The Future Looks Brighter After 25 Years of Retinal Gene Therapy.
Hum Gene Ther. 2017 Nov;28(11):982-987. doi: 10.1089/hum.2017.164. Epub 2017 Aug 20.
4
Gene therapy for retinal degeneration.
Ophthalmic Res. 1997;29(5):261-8. doi: 10.1159/000268024.
5
Recent breakthroughs in gene therapy for inherited retinal degeneration.
Discov Med. 2009 Oct;8(42):125-9.
6
Gene therapy in hereditary retinal degeneration and the tower of Babel.
Br J Ophthalmol. 2001 Mar;85(3):255. doi: 10.1136/bjo.85.3.255.
7
[Brain tumor therapy using replication--competent virus vectors].
Nihon Rinsho. 2005 Sep;63 Suppl 9:504-9.
8
An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse.
Br J Ophthalmol. 2001 Mar;85(3):341-4. doi: 10.1136/bjo.85.3.341.
9
Preliminary results of gene therapy for retinal degeneration.
N Engl J Med. 2008 May 22;358(21):2282-4. doi: 10.1056/NEJMe0803081. Epub 2008 Apr 27.
10
Adenoviral-mediated gene transfer to retinal explants during development and degeneration.
Exp Eye Res. 2004 Aug;79(2):189-201. doi: 10.1016/j.exer.2004.03.010.
引用本文的文献
1
AAV2/4-RS1 gene therapy in the retinoschisin knockout mouse model of X-linked retinoschisis.
PLoS One. 2022 Dec 7;17(12):e0276298. doi: 10.1371/journal.pone.0276298. eCollection 2022.
2
Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.
Gene Ther. 2009 Jan;16(1):10-6. doi: 10.1038/gt.2008.115. Epub 2008 Jul 17.
3
Lentiviral mediated gene delivery to the anterior chamber of rodent eyes.
Mol Vis. 2005 Jun 21;11:425-30.
4
Molecular ophthalmology: an update on animal models for retinal degenerations and dystrophies.
Br J Ophthalmol. 2000 Aug;84(8):922-7. doi: 10.1136/bjo.84.8.922.
5
Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization.
Am J Pathol. 2000 Jul;157(1):135-44. doi: 10.1016/S0002-9440(10)64525-7.
6
Matrix metalloproteinase biology applied to vitreoretinal disorders.
Br J Ophthalmol. 2000 Jun;84(6):654-66. doi: 10.1136/bjo.84.6.654.
7
Molecular therapy in ocular wound healing.
Br J Ophthalmol. 1999 Nov;83(11):1219-24. doi: 10.1136/bjo.83.11.1219.
8
Management of inherited outer retinal dystrophies: present and future.
Br J Ophthalmol. 1999 Jan;83(1):120-2. doi: 10.1136/bjo.83.1.120.
本文引用的文献
1
Virosomes: cationic liposomes enhance retroviral transduction.
Nat Biotechnol. 1996 Mar;14(3):339-42. doi: 10.1038/nbt0396-339.
2
Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: feasibility in prevention of proliferative vitreoretinopathy.
Hum Gene Ther. 1996 May 1;7(7):799-808. doi: 10.1089/hum.1996.7.7-799.
3
Measuring success in clinical gene therapy research.
Mol Med Today. 1996 Jun;2(6):234-6. doi: 10.1016/1357-4310(96)88803-4.
4
Gene transfer into the mouse retina mediated by an adeno-associated viral vector.
Hum Mol Genet. 1996 May;5(5):591-4. doi: 10.1093/hmg/5.5.591.
5
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells.
J Virol. 1996 Jul;70(7):4646-54. doi: 10.1128/JVI.70.7.4646-4654.1996.
6
A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3).
Nat Genet. 1996 May;13(1):35-42. doi: 10.1038/ng0596-35.
7
Ocular adenovirus gene transfer varies in efficiency and inflammatory response.
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1282-93.
8
Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy.
Nat Med. 1996 Jun;2(6):649-54. doi: 10.1038/nm0696-649.
9
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors.
J Virol. 1996 May;70(5):3227-34. doi: 10.1128/JVI.70.5.3227-3234.1996.
10
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
Science. 1996 Apr 12;272(5259):263-7. doi: 10.1126/science.272.5259.263.
Zotero 插件